Worley Marcia M
University of Minnesota, College of Pharmacy, Duluth, MN 55812-3095, USA.
Res Social Adm Pharm. 2006 Mar;2(1):1-21. doi: 10.1016/j.sapharm.2005.12.006.
Considering recent changes to the Medicare program, pharmacists will have unique opportunities to be reimbursed for providing Medication Therapy Management Services to older persons with diabetes. A high-quality pharmacist-patient relationship can lay the foundation for effective provision of Medication Therapy Management Services and improved care in this cohort.
To test a pharmacist-patient relationship quality model in a group of older persons with diabetes from the patient's perspective. Antecedents to relationship quality were pharmacist participative behavior/patient-centeredness of relationship, patient participative behavior, and pharmacist-patient interpersonal communication. Pharmacist-patient relationship commitment was the outcome of relationship quality studied.
Data were collected via mailed questionnaire from a random sample of 600 community-dwelling adults in the United States who (1) were 65 years of age and older, (2) had type 1 or type 2 diabetes, (3) used at least one prescription medication to treat their diabetes, and (4) used some type of nonmail order pharmacy as their primary source of obtaining prescription medications. Model relationships were tested using path analysis.
The adjusted response rate was 41.6% (221/531). The models explained 47% and 49% of the variance in relationship quality and relationship commitment, respectively. In the relationship quality model, pharmacist participative behavior/patient-centeredness of relationship (beta=.51, P<.001) and pharmacist-patient interpersonal communication (beta=.17, P=.008) had direct effects on relationship quality. In the relationship commitment model, relationship quality had a direct effect on relationship commitment (beta=.60, P<.001). Pharmacist participative behavior/patient-centeredness and pharmacist-patient interpersonal communication had indirect effects on relationship commitment through their effects on relationship quality, which is a mediator in the model.
Results affirm findings from previous research showing that patients' perceptions of pharmacist participative behavior/patient-centeredness of relationship and pharmacist-patient interpersonal communication are positively related to perceptions of relationship quality. Also, relationship quality is a strong mediator between pharmacist participative behavior/patient-centeredness of relationship and relationship commitment, as well as between pharmacist-patient interpersonal communication and relationship commitment.
考虑到医疗保险计划最近的变化,药剂师将有独特的机会因向老年糖尿病患者提供药物治疗管理服务而获得报销。高质量的药剂师-患者关系可为有效提供药物治疗管理服务及改善该群体的护理奠定基础。
从患者角度在一组老年糖尿病患者中测试药剂师-患者关系质量模型。关系质量的前因包括药剂师的参与行为/关系的以患者为中心、患者的参与行为以及药剂师-患者人际沟通。药剂师-患者关系承诺是所研究的关系质量的结果。
通过邮寄问卷从美国600名社区居住成年人的随机样本中收集数据,这些成年人需满足以下条件:(1)年龄在65岁及以上;(2)患有1型或2型糖尿病;(3)使用至少一种处方药治疗糖尿病;(4)将某种非邮购药房作为获取处方药的主要来源。使用路径分析测试模型关系。
调整后的回复率为41.6%(221/531)。这些模型分别解释了关系质量和关系承诺中47%和49%的方差。在关系质量模型中,药剂师的参与行为/关系的以患者为中心(β = 0.51,P <.001)和药剂师-患者人际沟通(β = 0.17,P = 0.008)对关系质量有直接影响。在关系承诺模型中,关系质量对关系承诺有直接影响(β = 0.60,P <.001)。药剂师的参与行为/以患者为中心以及药剂师-患者人际沟通通过对关系质量的影响对关系承诺有间接影响,关系质量是该模型中的一个中介变量。
结果证实了先前研究的发现,即患者对药剂师参与行为/关系的以患者为中心以及药剂师-患者人际沟通的认知与对关系质量的认知呈正相关。此外,关系质量是药剂师参与行为/关系以患者为中心与关系承诺之间以及药剂师-患者人际沟通与关系承诺之间的有力中介变量。